A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Elarekibep in Healthy Japanese Subjects

Trial Identifier: D2912C00002
Sponsor: AstraZeneca
Collaborator:
Parexel
Start Date: April 2023
Primary Completion Date: July 2023
Study Completion Date: July 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
GB Harrow, GB, HA1 3UJ